Profile photo Joost Verhoeff

Joost Verhoeff

Associate Professor - medical

Strategic program(s):

Biography

View my YouTube research presentation (in Dutch):

MRI-geleide radiotherapie in Utrecht: Harder, Better, Faster, Stronger https://youtu.be/aJerM2wQoKI?t=152

 

Performing research is expensive. If you want to support us to speed things up, please contact me.

T. 088 - 75 588 00 E. j.j.c.verhoeff-10@umcutrecht.nl

 

My lab's mission is to redefine Standard Radiotherapy

As radiation oncologists, we want to treat cancer patients with high precision radiotherapy. The UMC Utrecht has the right team and right machinery for this (3x MRI-linac, 10x CT-linac). My lab's goal is to design the best cancer treatment for each patient. Some patients want to live as long as possible regardless of treatment side effects, others want quality of life. To find balance is key.

The UMC Utrecht department of Radiation Oncology is a terrific place to do clinical research, as it is even the birthplace of the MRI-linac. Next, the Radiation Oncology department harbours 2 1.5T MRI systems, a 3.0T MRI, a 7.0T MRI and a MRI/PET scanner.

Joost Verhoeff subspecialized in treatment of brain tumors, lung cancer and cardiac SBRT. About half of his time he spends on research as associate professor.

 

Brain tumors:

- Increasing quality of life by compact but extremely precise focused radiation treatment

- Increasing overall survival by combining better treatment modalities

- Principal Investigator of ZonMW funded GOLD trial (dutch info), 30x2Gy+TMZ versus 6x6Gy+TMZ for primary GBM (responsible researcher drs. Arthur van der Boog)

- Principal Investigator of KWF funded RISinG trial (dutch info), 10x3.5Gy versus 4x7.5Gy for recurrent GBM (responsible researcher drs. Arthur van der Boog)

 

Brain metastases:

- Finding best treatments for each specific patient: personalized medicine.

- Increasing quality of life by incorporating MR-guided treatment post operative (MRI-linac)

- Coimbra brain metastasis prospective cohort (website, clinicaltrials.gov) (responsible researcher drs. Fia Cialdella)

 

Lung cancer:

- Better predicting patient survival and toxicity by smart analyses

- Increasing quality of life by incorporating MR-guided treatment (MR-Linac)

- U-color prospective cohort, for all lung cancer patients that receive radiotherapy

 

Cardiac Ablative SBRT:

- In the lead of a consortium of 30 European hospitals we develop strategies to treat Ventricular Tachycardia in the STOPSTORM.eu framework (Principal Investigator, EU H2020 grant).

 

Postdocs:

- Szabolcs David PhD (brain tumors, imaging)
- Jacqueline Pomp MD PhD, radiation oncologist, (lung cancer and deep learning)
- Peter van Rossum MD PhD MSc, resident radiation oncologist (MRI-linac, epidemiology, lung cancer)

 

PhD students:

- Eva van Grinsven MSc (neuro-psychology, brain tumors)
- Arthur van der Boog BS (brain tumors, clinical trials)
- Belle van Duin MD (melanoma, imaging, pathology)
- Fia Cialdella MD (brain metastases, neuro-oncology)

 

Residents radiation oncology performing research:

- Joyce Lodeweges MD (lung cancer)
- Max Peters MD PhD MSc (epidemiology, lung cancer)
- Pim Damen MD (immunotherapies)
- Emma Wolters MD PhD (neuro oncology)
- Rosa Sleddering MD (neuro oncology)

 

Students (medical, biomedical, informatics):

- Michelle Sierts (MR-Linac for brain tumors)
- Karlijn Smitt (brain tumors)
- Lucie Egberink (lung cancer)
- Myra van Laar (lung cancer)

Former group members (medical, biomedical, informatics):

- Steven Nagtegaal MD PhD (brain tumors, cognitive changes)
- Wouter van Amsterdam MD PhD (deep learning, lung cancer)
- Selena Huisman (brain tumor imaging)
- Victor Wasser (brain tumor imaging)
- Salah Gasle (brain tumor imaging)
- Mathijs Tomassen (lung cancer)
- Sjors Witteveen (lung cancer)
- Hajo Boersma (psychiatric disorders and radiotherapy)
- Hugo van Joolingen (lung cancer)
- Anne van der Tuin (MR-Linac for lung cancer)
- Eva Swinkels (lung cancer)
- Marnix Rading MD (lung cancer)
- Laura Merckel MD PhD (MRI-linac lung cancer)
- Bas Arends (deep learning for spine tumor treatment)
- Jasper Hennecken (spinal imaging)
- Céline Bogers (lung cancer)
- Eliza van Wulfften Palthe (brain metastases)
- Anouk Steennis (brain tumors)
- Ali Ghannam (brain metastases cohort)
- Emma Nessen (brain metastases)
- Marc Pijper (lung cancer)
- Cathalijne Post (brain tumors)
- Robin Schuijlenburg (brain tumors)
- Merel Kraak (lung cancer)
- Suzanne Vellinga (lung cancer)
- Netanja Harlianto (lung cancer)
- Yannic Hanekamp (Covid treatment)
- Sjors Wagemakers (pain meassurement)
- Max van Essen (brain tumors)
- Chris Hammerstein (survival analyses)

 

 

 

Full list of publications on PubMed: click here (automatic list is incomplete)

Strategic program(s):

Contact

Recent publications

Comparison of 18F-FET-PET- and MRI-based target definition for re-irradiation treatment of recurrent diffuse glioma Albert Everard, Daniel Versnel, Veerle Ruijters, Nelleke Tolboom, Marielle Philippens, Tom Snijders, Joost Verhoeff, Szabolcs David, Casper Beijst
Clinical and translational radiation oncology, 2025, vol. 52
Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists J. M. Westerhoff, F. J. Raaijmakers, L. A. Daamen, E. N. de Groot-van Breugel, L. T.C. Meijers, J. R.N. van der Voort van Zyp, J. J.C. Verhoeff, S. Mook, H. M. Verkooijen, M. P.W. Intven
Clinical and translational radiation oncology, 2025, vol. 51
Deep learning on CT scans to predict checkpoint inhibitor treatment outcomes in advanced melanoma Laurens S Ter Maat, Rob A J De Mooij, Isabella A J Van Duin, Joost J C Verhoeff, Sjoerd G Elias, Tim Leiner, Wouter A C van Amsterdam, Max F Troenokarso, Eran R A N Arntz, Franchette W P J Van den Berkmortel, Marye J Boers-Sonderen, Martijn F Boomsma, Fons J M Van den Eertwegh, Jan Willem de Groot, Geke A P Hospers, Djura Piersma, Art Vreugdenhil, Hans M Westgeest, Ellen Kapiteijn, Ardine A De Wit, Willeke A M Blokx, Paul J Van Diest, Pim A De Jong, Josien P W Pluim, Karijn P M Suijkerbuijk, Mitko Veta
Scientific Reports, 2024, vol. 14
The influence of cardiac substructure dose on survival in a large lung cancer stereotactic radiotherapy cohort using a robust personalized contour analysis Luuk H.G. van der Pol, Jacquelien Pomp, Firdaus A.A. Mohamed Hoesein, Bas W. Raaymakers, Joost J.C. Verhoeff, Martin F. Fast
Physics and Imaging in Radiation Oncology, 2024, vol. 32
Validation of SynthSeg segmentation performance on CT using paired MRI from radiotherapy patients Selena Huisman, Matteo Maspero, Marielle Philippens, Joost Verhoeff, Szabolcs David
NeuroImage, 2024, vol. 303
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR) Luuk H G van der Pol, Oliver Blanck, Melanie Grehn, Tomáš Blazek, Lukáš Knybel, Brian V Balgobind, Joost J C Verhoeff, Marcin Miszczyk, Slawomir Blamek, Sabrina Reichl, Nicolaus Andratschke, Felix Mehrhof, Judit Boda-Heggemann, Bartłomiej Tomasik, Stefano Mandija, Martin F Fast
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2024, vol. 202